Daidian Duo Tablet 5/850 mg
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
HanKook HyuTex Pharmaceutical Co., Ltd.
MFDS item code 202201349 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is prescribed to help improve blood glucose control in adult patients with type 2 diabetes. It is particularly used as an adjunct to diet and exercise by combining empagliflozin with metformin. It is effective for patients whose blood glucose is not adequately controlled and caution is required when administering to individuals with cardiovascular diseases. This medication is used to enhance blood glucose control and improve the patient's health condition.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is required for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). Elderly Patients In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This medication is an antidiabetic that helps to control blood glucose. Care should be taken when taking this medication, as a rare side effect called severe lactic acidosis may occur. Lactic acidosis can lead to a dangerous state with excessive lactic acid buildup in the body, which can be fatal. Additionally, when taken with insulin or sulfonylureas, severe hypoglycemia can occur, so caution is necessary. Patients with moderate or severe renal impairment or acute kidney injury should not take this medication. It should also be avoided in the presence of acute illnesses such as dehydration, severe infections, heart failure, or acute myocardial infarction, and if surgery is planned, the medication should be discontinued 48 hours before the procedure. Women who are pregnant or breastfeeding should not take this medication. This medication is affected by renal function, so regular blood tests should be conducted to monitor kidney function. Particularly, elderly patients or those with impaired renal function should undergo testing more frequently. During use, there is a risk of hypoglycemia, so patients should maintain regular meal patterns and adjust their exercise and medication dosages accordingly. This medication can cause gastrointestinal disturbances (diarrhea, vomiting, abdominal pain, etc.) and may lead to urinary or genital infections, so if symptoms occur, a doctor should be consulted immediately. Due to the risk of reduced fluid volume, care should be taken to avoid dehydration and notify the healthcare provider if symptoms of low blood pressure appear. This medication may lower vitamin B12 levels, so regular testing may be necessary. Alcohol may increase the risk of side effects associated with this medication, so excessive drinking should be avoided. While taking this medication, it is necessary to stop taking it for a certain period before and after tests using iodine contrast agents, and it should only be resumed after ensuring normal kidney function. This medication must be taken according to the prescribed dose and the doctor's instructions, and any abnormal symptoms should be reported to healthcare providers immediately.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain room temperature between 1 degree and 30 degrees Celsius. This ensures that the medication remains effective and safe to use.
A yellowish-white, bilaterally convex, oval film-coated tablet
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
HanKook HyuTex Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.